IBG Beteiligungsgesellschaft Sachsen-Anhalt

IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH is a venture capital firm located in Magdeburg, Germany, specializing in seed, start-up, early venture, growth stage, and mezzanine investments. Established in 2000, the firm primarily targets technology-oriented companies in the German state of Saxony-Anhalt, focusing on sectors such as computer software, industrial products, environmental technology, healthcare, biotechnology, and renewable energies. IBG Beteiligungsgesellschaft typically invests up to €10 million per company, aiming for minority stakes of up to 24.9 percent and intending to hold investments for five to seven years. The firm is also open to co-investment opportunities, further supporting innovation and growth in various high-tech industries.

Matthias Stübig

Managing Director

25 past transactions

livil

Venture Round in 2024
Livil is a company that specializes in providing a toolkit for designing and delivering flexible employee benefits. Their offerings include lifestyle, dental, and vision plans, aimed at enhancing employee satisfaction and well-being. By focusing on customizable benefit solutions, Livil addresses the diverse needs of modern workforces, allowing organizations to tailor their offerings to better support their employees. This approach not only fosters employee engagement but also helps companies retain talent by providing competitive benefits packages.

Intelligent Fluid

Series B in 2023
Intelligent Fluids GmbH is a technology company specializing in the development of innovative, high-performance cleaning fluids that utilize a patented technology combining gentle ingredients to create dynamic phase fluids. These fluids are designed for specific applications and function effectively without chemical dissolving or etching, making them safe for users, equipment, and the environment. They are particularly suited for industries such as microelectronics, industrial maintenance, optics, printing, and building protection, among others. The company's products facilitate the removal of dirt, residues, coatings, and lacquers, offering significant advantages in process optimization and cost savings. Additionally, Intelligent Fluids is committed to sustainability, supporting multiple UN Sustainable Development Goals by reducing carbon emissions, energy consumption, and material use. Beyond its product line, the company also engages in joint development and private label agreements, further broadening its impact in the eco-friendly cleaning sector.

InLine-Med

Seed Round in 2022
InLine-Med GmbH, established in 2019 and based in Magdeburg, Germany, specializes in developing assistance devices that enhance the efficiency and accuracy of needle-based interventions for radiologists. The company offers a range of products, including navigation devices, surgical tools, needle alignment tools, and anatomical marker grids, along with navigation software that aids in visualization and intervention planning. By integrating artificial intelligence with innovative guiding tools and high-quality biopsy needles, InLine-Med addresses the challenges of accurate needle placement, which is crucial in cancer diagnosis and treatment. Their solution allows clinicians to define a needle trajectory on a computer and seamlessly translate this plan to the patient, minimizing the need for multiple punctures and reducing procedure times. The comprehensive suite of assistance tools is competitively priced, enabling clinicians to conduct safe and precise interventions without relying on complex robotic systems.

Wingfield

Series A in 2022
Wingfield GmbH, founded in 2017 and based in Hanover, Germany, specializes in developing a software system that transforms any tennis court into a smart court. This innovative system integrates hardware and artificial intelligence to track scores, analyze strokes, and provide personalized feedback immediately after matches or practice sessions. Wingfield's technology offers amateur players access to advanced game analytics typically reserved for professionals, all at a fraction of the cost of traditional systems. Additionally, the user-friendly setup enables coaches to effectively plan and review their players' training progress, enhancing the overall tennis experience for both players and coaches alike.

livil

Seed Round in 2022
Livil is a company that specializes in providing a toolkit for designing and delivering flexible employee benefits. Their offerings include lifestyle, dental, and vision plans, aimed at enhancing employee satisfaction and well-being. By focusing on customizable benefit solutions, Livil addresses the diverse needs of modern workforces, allowing organizations to tailor their offerings to better support their employees. This approach not only fosters employee engagement but also helps companies retain talent by providing competitive benefits packages.

Baby Sweets

Seed Round in 2018
Baby Sweets is an online retailer specializing in distinctive and high-quality baby clothing and accessories. The company offers a diverse range of products, including bodysuits, rompers, pajamas, and caps, alongside unique themed accessories designed for infants. By featuring both its own EU-made brands and select international brands, Baby Sweets provides parents with a comprehensive selection of essential items for their children's early years. The emphasis on eye-catching designs and quality ensures that Baby Sweets meets the needs of modern parents seeking stylish and functional apparel for their babies.

Coman Software

Venture Round in 2018
COMAN Software GmbH specializes in developing software solutions tailored for machine and plant construction. Founded in 2018 and headquartered in Gardelegen, Germany, the company offers a project management platform that enhances efficiency and transparency in construction projects. Key features include real-time data capture, easy import of project data, automated status report generation, and mobile access to project information. This software aims to optimize project planning and execution, reduce construction times, and minimize errors through centralized data management and streamlined communication. Additionally, COMAN Software provides various services, including support, training, and consulting, to assist clients in effectively utilizing their platform. The company's innovative approach enables businesses to enhance collaboration, stay on schedule, and manage projects within budget.

Lab-on-Fiber

Seed Round in 2018
Lab-on-Fiber GmbH, based in Halle, Germany, specializes in the development and production of advanced medical laser probes and systems aimed at enhancing minimally invasive surgical procedures. The company offers a range of fiber delivery systems, including surgical and urology fiber probes. By providing optimized radiation profiles and real-time temperature monitoring at the probe surface, Lab-on-Fiber's technology helps surgeons reduce operating times, improve treatment outcomes, and enhance patient safety. Their innovative solutions are designed to streamline laser surgery while minimizing potential complications, positioning Lab-on-Fiber as a key player in the medical technology sector.

Urwahn

Venture Round in 2018
Urwahn Engineering is a developer of innovative bicycles aimed at enhancing urban mobility. The company focuses on creating bicycles that combine a purist design with practical features suitable for daily use. Their products are equipped with integrated LED lighting and GPS tracking systems, catering specifically to the needs of urban commuters. By offering smart and sustainable mobility solutions, Urwahn Engineering seeks to revolutionize the cycling experience in urban environments.

DCI Digital Car Institute

Venture Round in 2017
DCI Digital Car Institute GmbH, based in Halle, Germany, specializes in developing advanced scan sensor software and solutions for the digital assessment of vehicle valuations and inspection reports. The company is recognized for its automated digitization technology that creates comprehensive 3D models of vehicles, facilitating accurate damage assessment and vehicle valuation. These models also support peer-to-peer marketing and innovative re-marketing strategies for automobiles. DCI caters to various clients, including vehicle fleet managers, leasing companies, insurance providers, and used car dealers, thereby enhancing their operations through efficient digital solutions. The institute focuses on integrating artificial intelligence into its products to pioneer new business models within the automotive sector.

TESVOLT

Series A in 2017
TESVOLT GmbH, established in 2014 and headquartered in Wittenberg, Germany, specializes in the development and manufacturing of lithium battery storage systems aimed at the commercial and industrial sectors. As a recognized leader in energy storage solutions in Germany and Europe, TESVOLT produces intelligent lithium storage systems with power capacities ranging from 10 kilowatt hours to several megawatt hours, all manufactured in a carbon-neutral gigafactory. Their products facilitate companies in reducing energy dependency and contribute to the transition toward renewable energy sources, including solar, wind, and biogas. The company has been acknowledged with various awards for its innovative approaches, driven by its co-founders Daniel Hannemann and Simon Schandert, who have extensive experience in the photovoltaic sector. TESVOLT's focus on developing economical storage solutions is complemented by its commitment to safety and quality, as evidenced by TÜV certification for its products.

Arzneimittelwerk Warngau

Series C in 2016
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

2tainment

Venture Round in 2016
2tainment GmbH is a video game publisher and developer based in Magdeburg, Germany, founded in 2014. The company specializes in creating and marketing both hardware and software entertainment products on an international scale. Its portfolio includes various games such as Tech Corp, BIOTOPE – Aquarium Simulator, Air Missions: HIND, Super Street, Club Manager 2017, and Crashday. In addition to game development, 2tainment focuses on enhancing player experiences through high-quality PC, mobile, and video game accessories, including game pads, charger stations, and keyboards. The company also emphasizes virtual and augmented reality, not only creating its own content but also supporting external studios. Beyond gaming, 2tainment engages in research and development projects, aiming to improve medical treatment methods through its expertise in VR and AR technologies. This dual focus on entertainment and healthcare positions 2tainment as a versatile player in the gaming industry.

Arzneimittelwerk Warngau

Series B in 2015
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

Micropelt

Venture Round in 2012
Micropelt is a startup that emerged from a collaborative project between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Germany. The company specializes in developing thin film thermoelectric components through semiconductor manufacturing processes. Micropelt focuses on creating energy-harvesting systems that integrate micro-actuators and sensors. Its product offerings include thermoelectric cooling chips and thermoelectric generators designed for various applications, such as chip spot cooling, biomedical devices, heating, ventilation, and air conditioning systems, as well as fiber optics. These innovations aim to facilitate effective temperature management in individual rooms while contributing to CO2 reduction and enhancing user comfort. The company has secured funding from several financial institutions, enabling its growth and development within the thin-film technology sector.

Vivoryon Therapeutics

Venture Round in 2012
Vivoryon Therapeutics AG is a clinical stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products for Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has completed Phase IIb clinical trials for Alzheimer's disease and is also being explored for cancer treatment. Additionally, Vivoryon is developing PQ1565, a small molecule inhibitor targeting glutaminyl-peptide cyclotransferase-like for cancer therapy, along with a monoclonal antibody aimed at enhancing the clearance of toxic pyroglutamate-Abeta. The company collaborates with various institutions, including the University Medical Center Schleswig-Holstein and Nordic Bioscience, to advance its clinical and research initiatives. Originally founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

TME Pharma

Series D in 2010
TME Pharma is a clinical-stage biopharmaceutical company focused on enhancing cancer treatment by targeting the tumor microenvironment. The company develops biostable aptamers and mirror image nucleic acids, with its leading drug candidates, NOX-A12 and NOX-E36, derived from a novel class of therapeutics known as Spiegelmers. These compounds are designed to improve the effectiveness of existing cancer therapies by offering specific advantages over traditional drug classes. TME Pharma maintains a strategic alliance with Pfizer, Inc., underscoring its commitment to advancing innovative treatment options in oncology. The company is headquartered in Berlin, Germany.

Vivoryon Therapeutics

Series B in 2009
Vivoryon Therapeutics AG is a clinical stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products for Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has completed Phase IIb clinical trials for Alzheimer's disease and is also being explored for cancer treatment. Additionally, Vivoryon is developing PQ1565, a small molecule inhibitor targeting glutaminyl-peptide cyclotransferase-like for cancer therapy, along with a monoclonal antibody aimed at enhancing the clearance of toxic pyroglutamate-Abeta. The company collaborates with various institutions, including the University Medical Center Schleswig-Holstein and Nordic Bioscience, to advance its clinical and research initiatives. Originally founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

KeyNeurotek Pharmaceuticals

Series C in 2009
KeyNeurotek is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases.

EUCODIS Bioscience

Venture Round in 2007
EUCODIS Bioscience GmbH is a manufacturer of enzyme solutions that cater to various industries, including biopharma, fine chemicals, and cosmetics. Established in 2007 and based in Vienna, Austria, with a subsidiary in Germany, the company produces a diverse range of enzymes such as lipases, peroxidases, and nitrile hydratases. These enzymes facilitate applications including the stereospecific resolution of chiral alcohols and acids for active pharmaceutical ingredient synthesis, the production of sensitive esters, and the selective hydrolysis of fatty acids. Additionally, EUCODIS offers services in protein and enzyme engineering, bioprocess development, and industrial manufacturing. Their products are utilized by leading companies in the chemical, pharmaceutical, food, and cosmetics sectors to enhance production efficiency and comply with environmental standards.

20/10 Perfect Vision

Venture Round in 2007
20/10 Perfect Vision has develops, manufactures and markets innovative technologies for raising refractive surgery well beyond current expectations. The company's FEMTEC femtosecond laser workstation is set to revolutionize the ophthalmic surgery market, while keeping ease-of-use and patient safety as primary objectives.

TME Pharma

Series C in 2007
TME Pharma is a clinical-stage biopharmaceutical company focused on enhancing cancer treatment by targeting the tumor microenvironment. The company develops biostable aptamers and mirror image nucleic acids, with its leading drug candidates, NOX-A12 and NOX-E36, derived from a novel class of therapeutics known as Spiegelmers. These compounds are designed to improve the effectiveness of existing cancer therapies by offering specific advantages over traditional drug classes. TME Pharma maintains a strategic alliance with Pfizer, Inc., underscoring its commitment to advancing innovative treatment options in oncology. The company is headquartered in Berlin, Germany.

MetraTec

Seed Round in 2006
metraTec GmbH is a German company that specializes in the manufacturing and supply of RFID hardware products. Based in Magdeburg and founded in 2006, metraTec offers a diverse range of products including HF and UHF readers, UHF gates, RFID readers/writers, antennas, transponders, and RFID modules. These products are utilized across various applications such as logistics, document management, access control systems, and e-ticketing. The company serves multiple industries, focusing primarily on logistics, healthcare, and security, and provides both standard and custom solutions to system integrators, OEM customers, and research institutions, particularly in Europe. In addition to RFID technology, metraTec also develops solutions for indoor localization, wireless mesh communication, and wireless power transmission, contributing to advancements in the Internet of Things. The company was previously known as metraTec RFID Solutions until its name change in 2008.

Curacyte AG

Series C in 2005
Curacyte GmbH is a biopharmaceutical company based in Munich, Germany, founded in 2001. It specializes in developing innovative therapeutics for acute and critical care, focusing on areas such as hematology, antithrombosis, and oncology. The company's research efforts aim to create advanced biopharmaceutics that address urgent medical needs, providing new treatment options for patients with critical diseases.

CSG Solar

Venture Round in 2005
CSG Solar is one of the leading players in thin-film solar technology. The company gets its name (Crystalline Silicon on Glass) from its technology, in which an extremely thin layer of silicon is deposited directly onto a glass sheet. This captures the already proven qualities of silicon in solar cells while significantly reducing the total amount of silicon required.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.